Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation

Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., Grote M., Valenta R.

Source: Eur Respir J 2011; 37: 44-52
Journal Issue: January
Disease area: Airway diseases, Respiratory infections

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Edlmayr J., Niespodziana K., Popow-Kraupp T., Krzyzanek V., Focke-Tejkl M., Blaas D., Grote M., Valenta R.. Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J 2011; 37: 44-52

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Antibody epitope and mimotope prediction of the viroporins M2 of the Influenza A virus, E of the Human SARS coronavirus and SH of the Respiratory Syncytial virus.
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019

An anti-human ICAM-1 antibody inhibits human rhinovirus infection in the mouse model of human major group rhinovirus infection
Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections
Year: 2011

Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia
Source: Virtual Congress 2020 – Translational science in respiratory infections
Year: 2020


Viral infections of the nose and lung
Source: ISSN=1025-448x, ISBN=1-904097-19-16, page=79
Year: 2001

Dual infection of infants by human metapneumovirus (hMPV) and human respiratory syncytial virus (hRSV) is strongly associated with severe bronchiolitis
Source: Annual Congress 2004 - Viral bronchiolitis in children: what's new in diagnosis and treatment?
Year: 2004


RSV and human metapneumovirus – major pathogens of childhood – also adults and the elderly?
Source: Annual Congress 2005 - Major viral threats to the lung
Year: 2005

COVID-19 vaccination and more
Source: ERS webinar 2021: COVID-19 vaccination and more
Year: 2021


LSC 2013 abstract - Mast cells support rhinovirus but not respiratory syncytial virus replication and contribute to the pro-inflammatory response to rhinovirus
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013

The role of viruses in chronic bronchitis and exacerbations of COPD
Source: Eur Respir Monogr 2013; 60: 68-75
Year: 2013


Potential inhibitors of respiratory syncytial virus (RSV) selected from a phage displayed random peptide library
Source: Eur Respir J 2002; 20: Suppl. 38, 158s
Year: 2002

Responses to rhinovirus infection in human lung slices are reduced by rupintrivir
Source: International Congress 2016 – Immune responses in the lung
Year: 2016

Glycosylation studies of G-protein of BA genotype of group B human respiratory syncytial virus in mammalian cells
Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Year: 2015

Serial viral infections in infants with recurrent respiratory illnesses
Source: Eur Respir J 2008; 32: 314-320
Year: 2008



Efficacy of IFN-λ1 to protect human airway epithelial cells against rhinovirus 1B infection
Source: Annual Congress 2013 –Viral infections
Year: 2013


Viruses in asthma and COPD: mechanisms and defence
Source: Annual Congress 2005 - Microorganisms: good, bad or ugly in allergic respiratory disease
Year: 2005

Neutrophil degranulation and cell lysis is associated with clinical severity in virus-induced asthma
Source: Eur Respir J 2002; 19: 68-75
Year: 2002



The effect of influenza virus infection on airway inflammation in a murine model of asthma
Source: Annual Congress 2013 –Macrophages, mononuclear cells and viral infection
Year: 2013

Abortive replication and reactivation in vitro respiratory syncytial virus (RSV) infection in palivizumab-treated HeLa cells
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Acutely lethal H1N1 influenza A virus infection alters the murine alveolar type II cell surfactant lipidome
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016

Long-term derangement of antigen presenting cells in the respiratory tract of mice following influenza virus infection
Source: Annual Congress 2013 –Research questions on how viruses affect the respiratory system
Year: 2013